Serum fatty acid binding protein 4 is positively associated with early stroke recurrence in nondiabetic ischemic stroke

Figures

• 

  Figure 1. Distribution of serum levels of FABP4 in different subgroups. (A) Serum levels of FABP4 in cardioembolic stroke and other stroke subtype groups. (B) Serum levels of FABP4 in obese and non-obese group. All data are medians and inter-quartile ranges (IQR). P values refer to Mann-Whitney U tests for differences between groups. FABP4= Fatty Acid Binding Protein 4.

• 

  Figure 2. Distribution of serum levels of FABP4 in ischemic stroke patients with stroke recurrence and without stroke recurrence. All data are medians and inter-quartile ranges (IQR). P values refer to Mann-Whitney U tests for differences between groups. FABP4= Fatty Acid Binding Protein 4.

• 

  Figure 3. The incidence for stroke recurrence in ischemic stroke according to the baseline FABP4 quartiles. Serum levels of FABP4 in Quartile 1 (<12.7ng/ml), Quartile 2 (12.7–17.7ng/ml), Quartile 3 (17.8–22.8ng/ml), and Quartile 4 (>22.8ng/ml). FABP4= Fatty Acid Binding Protein 4.

• 

  Figure 4. Receiver operator characteristic curve demonstrating sensitivity as a function of 1 specificity for predicting the stroke recurrence. Based on the logistic model incorporating 2 biomarkers (FABP4/NIHSS) and the relative contribution of each biomarker alone (FABP4/NIHSS/Hs-CRP/HCY). NIHSS=National Institutes of Health Stroke Scale; Hs-CRP=High C-reactive protein; HCY=Homocysteine; FABP4=Fatty Acid Binding Protein 4.